MedPath

Natural History and Biological Study of Netherton Syndrome

Not Applicable
Completed
Conditions
Netherton Syndrome
Healthy
Registration Number
NCT02081313
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Brief Summary

This study aims at studying the natural history of Netherton syndrome (NS), to identify the consequences of LEKTI deficiency on the immune system and to characterize new molecular mechanisms involved in the disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Adult or child (no age limit)
  • Confirmed diagnosis of Netherton syndrome
  • Signed informed consent form for the patient or his legal representative
Exclusion Criteria
  • Bleeding disorder precluding skin biopsy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Measurement of seric cytokines levels3 months after patient recruitment
Secondary Outcome Measures
NameTimeMethod
Pattern of skin abnormalities3 months after patient recruitment

Trial Locations

Locations (1)

Imagine Institute for genetic diseases

🇫🇷

Paris, France

Imagine Institute for genetic diseases
🇫🇷Paris, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.